FindTrial
Sign In

A Protein Study on Osteoarthritis of Knee treated with Rhus toxicodendron 200

A PROTEOMIC STUDY OF PATIENT WITH CLINICAL SYMPTOMS OF OSTEOARTHRITIS OF KNEE TREATED WITH RHUS TOXICODENDRON IN 200th POTENCY - PORT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033149
Enrollment
30
Registered
2021-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M17- Osteoarthritis of knee

Interventions

Intervention1: RHUS TOXICODENDRON IN 200th Potency: Rhus toxicodendron will be given in 200th potency in 2 grain lactose at every 6 hour orally for 90 days Control Intervention1: NOT APPLICABLE: NOT A

Sponsors

Sarada Krishna Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Osteoarthritis with other associated disease like hypercholesteraemia and obesity. 2.Patients who indicate the symptoms of rhus toxicodendron especially in

Exclusion criteria

Exclusion criteria: 1.Patients suffering from other severe systemic diseases. 2.Patient for whom Rhus toxicodendron is not the indicated medicine.

Design outcomes

Primary

MeasureTime frame
To understand the effectiveness of Rhus toxicodendron at the level of protein in OA knee. Timepoint: 2 Weeks—

Secondary

MeasureTime frame
To identify the protein responsible for OA knee. To explore the action of homoeopathic remedy Rhus toxicodendron with proteomics.Timepoint: 2 Weeks—

Countries

India

Contacts

Public ContactNandhini

Sarada Krishna Homoeopathic Medical College and Hospital

drwinstonv@gmail.com9443692478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026